Weight-loss drugs enter the longevity debate, Japan crosses a remarkable demographic threshold, an alleged assault aboard a Navy vessel becomes entangled in workers’ compensation law, and FBI hiring rules produce one of Capitol Hill’s strangest exchanges.

On today's TMI Show with Ted Rall and Manila Chan...

Ozempic and Wegovy transformed the treatment of diabetes and obesity. Now, new research is testing whether the drugs could influence aging itself. The early findings are attention-grabbing, but the limits and potential risks deserve just as much attention as the promise.

Japan has reached a longevity milestone no country has seen before. Behind that achievement lies a growing national challenge involving a shrinking population, rising social costs and an economy increasingly responsible for supporting its oldest citizens.